Akero Therapeutics
AKRO
AKRO
146 hedge funds and large institutions have $1.73B invested in Akero Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% more funds holding
Funds holding: 113 → 146 (+33)
5% more ownership
Funds ownership: 104.87% → 109.88% (+5%)
44% less call options, than puts
Call options by funds: $23.7M | Put options by funds: $42.1M
Holders
146
Holding in Top 10
7
Calls
$23.7M
Puts
$42.1M
Top Buyers
| 1 | +$187M | |
| 2 | +$106M | |
| 3 | +$76.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.3M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$32.7M |
Top Sellers
| 1 | -$53.6M | |
| 2 | -$42.2M | |
| 3 | -$23.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$8.68M |